Log in to your Inderes Free account to see all free content on this page.
aXichem
1.3
SEK
-11.26 %
AXIC A
First North Stockholm
Chemicals
Basic Materials
Be the first to follow this company
-11.26%
-11.56%
-8.13%
+4.84%
-66.59%
-82.28%
-94.15%
-98.45%
-92.3%
www.axichem.com
aXichem is active in industrial biotechnology. The company develops, patents and markets industrial chemicals. The company mainly works with Phenylcapsaicin, a natural analog synthetic capsaicin with applications in a variety of areas, such as in the marine sector, among pest control in forestry and agriculture, as well as among individual pharmaceutical work areas. Operations are run on a global level, with the head office in Malmö.
Revenue
1.81M
EBIT %
-956.91 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
AXIC A
Daily low / high price
1.3 / 1.445
SEK
Market cap
76.85M SEK
Turnover
165.85K SEK
Volume
122K
Financial calendar
Annual report
27.02.2025
Interim report
22.05.2025
General meeting
18.06.2025
Interim report
28.08.2025
Interim report
28.11.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
LMK Bolagen | 15.5 % | 15.5 % |
Manakin Ltd | 7.2 % | 7.2 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
aXichem AB: aXichem secures production capacity for phenylcapsaicin, corresponding to volumes of up to 100 tons of aXiphen-feed, for the upcoming six to nine months
aXichem AB: aXichem exhibits at Vitafoods Europe 2021 in Geneva, and launches a new website presenting the unique product aXivite
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio